# Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

> **NCT00652327** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 83 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Ezetimibe + Statin (simvastatin, atorvastatin, or pravastatin)
- **DRUG:** Double Statin (simvastatin, atorvastatin, or pravastatin)

## Key facts

- **NCT ID:** NCT00652327
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652327, "Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00652327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*